National

Opposition leaders briefed on COVID-19 pandemic

Darpan News Desk The Canadian Press, 19 Nov, 2020 11:44 PM

Federal opposition leaders have been given an advance look at grim new projections for the spread of COVID-19 in Canada.

Updated modelling that is expected to show the number of new cases rising dramatically over the next month is to be released Friday.

Prime Minister Justin Trudeau invited opposition leaders to attend a confidential briefing today with chief public health officer Dr. Theresa Tam and her deputy, Dr. Howard Njoo.

Conservative Leader Erin O'Toole says the briefing left him with the belief that Canada is "worse off" now than it was at the start of the pandemic in March.

NDP Leader Jagmeet Singh calls the projected case numbers "troubling" and Green Leader Annamie Paul says the briefing was "sobering."

The Prime Minister's Office says the purpose of the briefing was to urge opposition leaders to put aside partisanship and join in a common effort to urge Canadians to strictly limit their contacts with people outside their households.

Prev Next

MORE National ARTICLES

Veterans groups to get $20M to weather COVID-19

The government first set aside $20 million for veterans groups that provide services to former military personnel in the COVID-19 relief bill passed by Parliament last month.

Veterans groups to get $20M to weather COVID-19

Toronto, Ontario record new COVID-19 record

Toronto reports 520 new cases of COVID-19 today, after recording 482 new cases Monday. British Columbia reported nearly 1,000 cases Monday, after implementing tougher new restrictions in the Vancouver area over the weekend.

Toronto, Ontario record new COVID-19 record

Man accused in van attack raises NCR defence

Minassian told a detective just hours after the incident that he carried out the attack as retribution against society because he was a lonely virgin who believed women wouldn't have sex with him.

Man accused in van attack raises NCR defence

Medicago reports promising COVID-19 vaccine tests

Medicago says the side effects were generally mild to moderate and short in duration. The Phase 1 clinical trial was a randomized, partially blinded study of 180 healthy people.

Medicago reports promising COVID-19 vaccine tests

Horgan gives first address after election victory

He says if B.C. residents want to avoid the heavier restrictions of the early days of the pandemic, they have to find safe ways to gather, celebrate and observe life events using technologies instead of meeting in person.